The Role of FOS and ORF57 in KSHV Infection
Examining how KSHV manipulates host proteins for viral replication.
― 5 min read
Table of Contents
- The Role of FOS in KSHV Infection
- How FOS Levels are Controlled
- The Importance of ORF57
- The Mechanism Behind FOS Regulation
- Interaction Between ORF57 and AEN
- The Role of RGS2
- The AKT Pathway
- Finding Host Genes Affected by KSHV
- Feedback Mechanisms
- Conclusion
- Future Directions
- Acknowledgments
- Original Source
- Reference Links
Kaposi's sarcoma-associated herpesvirus, known as KSHV, is a type of virus linked to specific cancers, including Kaposi's sarcoma, body cavity-based lymphoma, and multicentric Castleman’s disease. KSHV operates in two main ways: the latent phase, where the virus remains inactive, and the lytic phase, where it replicates and spreads. Understanding how KSHV causes diseases is crucial for developing treatments.
The Role of FOS in KSHV Infection
FOS is a protein that plays an important role in cell actions like growth and death. It can form pairs with other proteins to create a complex known as AP-1, which helps control the activity of several genes. Different factors, including infections, can quickly boost the amount of AP-1 made by cells.
During KSHV's active lytic phase, FOS is particularly important. It helps increase the levels of KSHV proteins, which are crucial for the virus to replicate. The virus uses FOS to turn on certain genes that help it thrive, making it essential for KSHV's life cycle.
How FOS Levels are Controlled
The levels of FOS in cells can be controlled in various ways. Research indicates that during KSHV's active phase, an increase in a specific protein called RTA raises FOS levels. Additionally, a cell signaling pathway known as MAPK contributes to this increase. FOS binds to the promoters of various genes, enhancing both viral and host gene expression.
The Importance of ORF57
One critical player in the KSHV lifecycle is the viral protein ORF57. This protein is vital for ensuring the virus can replicate effectively and is necessary for the stability of FOS RNA. ORF57 interacts with host RNAs, protecting them from being destroyed too quickly. It stabilizes FOS RNA, allowing for higher levels of the FOS protein to be produced during KSHV's active phase.
ORF57's Effect on Host Genes
The KSHV ORF57 protein affects multiple host genes during the virus's lytic infection. Researchers have developed specific antibodies that target ORF57 to study its interactions with host RNAs. By doing so, they can identify which host RNAs are associated with ORF57 during infection, helping to show how the virus manipulates host cell machinery for its benefit.
The Mechanism Behind FOS Regulation
Recent studies have shown how ORF57 regulates FOS levels during KSHV infection. It binds to a specific region of FOS RNA, preventing it from breaking down quickly, hence extending its lifespan. This interaction is crucial, as sustaining FOS levels activates various genes that support KSHV's replication and overall survival.
Interaction Between ORF57 and AEN
Another important aspect of this interaction is a host protein called AEN, which can destabilize FOS RNA. When levels of FOS increase due to ORF57's action, AEN levels decrease. In turn, FOS appears to suppress AEN expression. This creates a feedback loop where high FOS levels can inhibit AEN, further stabilizing FOS RNA.
The Role of RGS2
RGS2 is another gene influenced by FOS during KSHV lytic infection. FOS activates RGS2, which plays an essential role in cell signaling pathways, particularly those that lead to cell growth and survival. Higher amounts of RGS2 can also contribute to activating pathways that lead to cell proliferation, including the important AKT signaling pathway.
The AKT Pathway
The AKT pathway is crucial for cell survival, growth, and metabolism. When FOS and RGS2 levels are elevated, they can lead to increased activation of AKT. This shows that KSHV not only manipulates the host's gene expression but also directs the signaling pathways that promote its survival and replication.
Finding Host Genes Affected by KSHV
Using advanced techniques like RNA sequencing, researchers can identify which host genes are turned on or off during KSHV infection. This helps create a list of genes that may be critical for KSHV’s life cycle and could be potential targets for therapies.
Feedback Mechanisms
In the context of KSHV infection, the interplay between FOS, AEN, and RGS2 creates a feedback loop that can enhance viral replication. As ORF57 stabilizes FOS, FOS increases RGS2, which in turn can enhance AKT phosphorylation. AEN acts as a destabilizer and is negatively regulated by FOS, creating a cycle that allows KSHV to thrive.
Conclusion
KSHV manipulates host cell machinery by interacting with key proteins and genes. The viral protein ORF57 plays a significant role in stabilizing host proteins like FOS, leading to changes in gene expression that favor viral replication. By understanding these mechanisms, researchers can identify potential new treatments for KSHV-related diseases.
Future Directions
Continued research on the interactions between KSHV proteins and host cellular factors is essential. By uncovering these mechanisms, new therapeutic strategies can be developed to combat the effects of KSHV infection and improve patient outcomes. Further studies are also needed to explore the potential roles of other host factors affected by KSHV, which could reveal new aspects of viral pathogenesis and host defense.
Acknowledgments
The findings discussed highlight the complex interactions between KSHV and host cellular mechanisms. As research advances, it is crucial to maintain an emphasis on validating results through experimental approaches, ensuring a comprehensive understanding of KSHV biology.
Title: KSHV promotes oncogenic FOS to inhibit nuclease AEN and transactivate RGS2 for AKT phosphorylation
Abstract: Kaposis sarcoma-associated herpesvirus (KSHV) ORF57 is a lytic RNA-binding protein. We applied BCBL-1 cells in lytic KSHV infection and performed UV cross-linking immunoprecipitation (CLIP) followed by RNA-seq of the CLIPed RNA fragments (CLIP-seq). We identified ORF57-bound transcripts from 544 host protein-coding genes. By comparing with the RNA-seq profiles from BCBL-1 cells with latent and lytic KSHV infection and from HEK293T cells with and without ORF57 expression, we identified FOS and CITED2 RNAs being two common ORF57-specific RNA targets. FOS dimerizes with JUN as a transcription factor AP-1 involved in cell proliferation, differentiation, and transformation. Knockout of the ORF57 gene from the KSHV genome led BAC16-iSLK cells incapable of FOS expression in KSHV lytic infection. The dysfunctional KSHV genome in FOS expression could be rescued by Lenti-ORF57 virus infection. ORF57 protein does not regulate FOS translation but binds to the 13-nt RNA motif near the FOS RNA 5' end and prolongs FOS mRNA half-life 7.7 times longer than it is in the absence of ORF57. This binding of ORF57 to FOS RNA is competitive to the binding of a host nuclease AEN (also referred to as ISG20L1). KSHV infection inhibits the expression of AEN, but not exosomal RNA helicase MTR4. FOS expression mediated by ORF57 inhibits AEN transcription, but transactivates RGS2, a regulator of G-protein coupled receptors. FOS binds a conserved AP-1 site in the RGS2 promoter and enhances RGS2 expression to phosphorylate AKT. Altogether, we have discovered that KSHV ORF57 specifically binds and stabilizes FOS RNA to increase FOS expression, thereby disturbing host gene expression and inducing pathogenesis during KSHV lytic infection. SignificanceWe discovered that FOS, a heterodimer component of oncogenic transcription factor AP- 1, is highly elevated in KSHV infected cells by expression of a viral lytic RNA-binding protein, ORF57, which binds a 13-nt RNA motif near the FOS RNA 5' end to prolong FOS RNA half-life. This binding of ORF57 to FOS RNA is competitive to the binding of host RNA destabilizer(s). KSHV infection inhibits expression of host nuclease AEN (or ISG20L1), but not MTR4. FOS inhibits AEN transcription, but transactivates RGS2 by binding to a conserved AP-1 site in the RGS2 promoter, thereby enhancing RGS2 expression and phosphorylation of AKT. Our data conclude that viral RNA-binding protein ORF57 controls the expression of a subset of genes for signaling, cell cycle progression, and proliferation to contribute viral pathogenesis.
Authors: Zhi-Ming Zheng, V. Majerciak, B. Alvarado-Hernandez, Y. Ma, S. Duduskar, A. Lobanov, M. Cam
Last Update: 2024-01-28 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.01.27.577582
Source PDF: https://www.biorxiv.org/content/10.1101/2024.01.27.577582.full.pdf
Licence: https://creativecommons.org/publicdomain/zero/1.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.